161 related articles for article (PubMed ID: 28085697)
1. AKT activation was not essential for hepatocellular carcinoma cell survival under glucose deprivation.
Zhou J; Tang Y; Xie ZJ; Lu JN; Deng JH; Huang XW; Chuan Hooi S; He M; Lu GD
Anticancer Drugs; 2017 Apr; 28(4):427-435. PubMed ID: 28085697
[TBL] [Abstract][Full Text] [Related]
2. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
3. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
Grabinski N; Ewald F; Hofmann BT; Staufer K; Schumacher U; Nashan B; Jücker M
Mol Cancer; 2012 Nov; 11():85. PubMed ID: 23167739
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated AKT inhibits the apoptosis induced by DRAM-mediated mitophagy in hepatocellular carcinoma by preventing the translocation of DRAM to mitochondria.
Liu K; Shi Y; Guo XH; Ouyang YB; Wang SS; Liu DJ; Wang AN; Li N; Chen DX
Cell Death Dis; 2014 Feb; 5(2):e1078. PubMed ID: 24556693
[TBL] [Abstract][Full Text] [Related]
5. IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway.
Li TT; Zhu D; Mou T; Guo Z; Pu JL; Chen QS; Wei XF; Wu ZJ
Mol Immunol; 2017 Jul; 87():132-140. PubMed ID: 28433890
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
7. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
Liu Y; Zhao Y; Guo L
Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
[TBL] [Abstract][Full Text] [Related]
8. Staurosporine suppresses survival of HepG2 cancer cells through Omi/HtrA2-mediated inhibition of PI3K/Akt signaling pathway.
Ding Y; Wang B; Chen X; Zhou Y; Ge J
Tumour Biol; 2017 Mar; 39(3):1010428317694317. PubMed ID: 28349827
[TBL] [Abstract][Full Text] [Related]
9. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
10. AKT-mediated phosphorylation of ATG4B impairs mitochondrial activity and enhances the Warburg effect in hepatocellular carcinoma cells.
Ni Z; He J; Wu Y; Hu C; Dai X; Yan X; Li B; Li X; Xiong H; Li Y; Li S; Xu L; Li Y; Lian J; He F
Autophagy; 2018; 14(4):685-701. PubMed ID: 29165041
[TBL] [Abstract][Full Text] [Related]
11. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
[TBL] [Abstract][Full Text] [Related]
12. The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma.
Zhang X; Yang H; Yue S; He G; Qu S; Zhang Z; Ma B; Ding R; Peng W; Zhang H; Yang Z; Dou K; Tao K; Li X
Cancer Med; 2017 Aug; 6(8):1941-1951. PubMed ID: 28675698
[TBL] [Abstract][Full Text] [Related]
13. PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Evers BM
J Surg Res; 2012 Aug; 176(2):542-8. PubMed ID: 22261591
[TBL] [Abstract][Full Text] [Related]
14. Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway.
Ye G; Qin Y; Wang S; Pan D; Xu S; Wu C; Wang X; Wang J; Ye H; Shen H
Cancer Biol Ther; 2019; 20(5):711-719. PubMed ID: 30755064
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of anaplastic lymphoma kinase promotes apoptosis and suppresses proliferation in human hepatocellular carcinoma.
Yu Z; Zhao R
Anticancer Drugs; 2018 Jul; 29(6):513-519. PubMed ID: 29570100
[TBL] [Abstract][Full Text] [Related]
17. [IL-12 induces autophagy via AKT/mTOR/STAT3 signaling pathway in human hepatoma cells].
Liu C; Xie C; Lin Y; Wu B; Wang Q; Li Z; Tu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):870-5. PubMed ID: 27363263
[TBL] [Abstract][Full Text] [Related]
18. Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma.
Wang J; Zheng X; Zeng G; Zhou Y; Yuan H
Int J Mol Med; 2014 Feb; 33(2):441-8. PubMed ID: 24337611
[TBL] [Abstract][Full Text] [Related]
19. AKT/mTOR signaling pathway is involved in salvianolic acid B-induced autophagy and apoptosis in hepatocellular carcinoma cells.
Gong L; Di C; Xia X; Wang J; Chen G; Shi J; Chen P; Xu H; Zhang W
Int J Oncol; 2016 Dec; 49(6):2538-2548. PubMed ID: 27779641
[TBL] [Abstract][Full Text] [Related]
20. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
